Patel Sujal M, CEO, President, and Secretary of Nautilus Biotechnology, Inc. ($NAUT), made five open market purchases totaling about $278 thousand over the last year. His most recent buy occurred on March 4, 2026. These $NAUT insider buys rank 1,221st among 4,983 individuals in our database, where the average purchase amount is $1.5 million across about 3.3 transactions. Patel Sujal M reported no open market sales in the past 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | Nautilus Biotechnology, Inc. | $NAUT | Patel Sujal M | CEO, President, and Secretary | P | Common Stock | 25000 | $2.61 | 17,461,232.0000 | 126,305,122 | 0.14% | 0.02% |
| March 2, 2026 | Nautilus Biotechnology, Inc. | $NAUT | Patel Sujal M | CEO, President, and Secretary | A | Stock Option (Right to Buy) | 650000 | $0.00 | 650,000.0000 | 126,305,122 | 9999.99% | 0.51% |
| Sept. 8, 2025 | Nautilus Biotechnology, Inc. | $NAUT | Patel Sujal M | CEO, President, and Secretary | P | Common Stock | 83500 | $0.68 | 17,436,232.0000 | 126,148,469 | 0.48% | 0.07% |
| Sept. 5, 2025 | Nautilus Biotechnology, Inc. | $NAUT | Patel Sujal M | CEO, President, and Secretary | P | Common Stock | 116500 | $0.67 | 17,352,732.0000 | 126,148,469 | 0.68% | 0.09% |
| March 19, 2025 | Nautilus Biotechnology, Inc. | $NAUT | Patel Sujal M | CEO, President, and Secretary | P | Common Stock | 53300 | $0.99 | 17,212,299.0000 | 126,148,469 | 0.31% | 0.04% |
| March 20, 2025 | Nautilus Biotechnology, Inc. | $NAUT | Patel Sujal M | CEO, President, and Secretary | P | Common Stock | 23933 | $1.00 | 17,236,232.0000 | 126,148,469 | 0.14% | 0.02% |
| March 3, 2025 | Nautilus Biotechnology, Inc. | $NAUT | Patel Sujal M | CEO, President, and Secretary | A | Stock Option (Right to Buy) | 650000 | $0.00 | 650,000.0000 | 126,148,469 | 9999.99% | 0.52% |
| March 11, 2024 | Nautilus Biotechnology, Inc. | $NAUT | Patel Sujal M | CEO, President, and Secretary | P | Common Stock | 12044 | $2.84 | 17,158,999.0000 | 0 | 0.07% | 0.00% |
| March 8, 2024 | Nautilus Biotechnology, Inc. | $NAUT | Patel Sujal M | CEO, President, and Secretary | P | Common Stock | 2430 | $2.99 | 17,146,955.0000 | 0 | 0.01% | 0.00% |
| March 5, 2024 | Nautilus Biotechnology, Inc. | $NAUT | Patel Sujal M | CEO, President, and Secretary | P | Common Stock | 7405 | $2.65 | 17,116,404.0000 | 0 | 0.04% | 0.00% |
| March 6, 2024 | Nautilus Biotechnology, Inc. | $NAUT | Patel Sujal M | CEO, President, and Secretary | P | Common Stock | 9267 | $2.70 | 17,125,671.0000 | 0 | 0.05% | 0.00% |
| March 7, 2024 | Nautilus Biotechnology, Inc. | $NAUT | Patel Sujal M | CEO, President, and Secretary | P | Common Stock | 18854 | $2.89 | 17,144,525.0000 | 0 | 0.11% | 0.00% |
| March 1, 2024 | Nautilus Biotechnology, Inc. | $NAUT | Patel Sujal M | CEO, President, and Secretary | A | Stock Option (Right to Buy) | 650000 | $0.00 | 650,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 27, 2023 | Nautilus Biotechnology, Inc. | $NAUT | Patel Sujal M | CEO, President, and Secretary | A | Stock Option (Right to Buy) | 650000 | $0.00 | 650,000.0000 | 0 | 9999.99% | 0.00% |